EPZ015666

EPZ015666

Catalog Number:
L002370764APE
Mfr. No.:
APE-B4989
Price:
$342
  • Size:
    Quantity:
    Add to Cart:
      • Overview
        • Please contact us at for specific academic pricing.

          Background

          EPZ015666 is a potent and selective inhibitor of PRMT5 with IC50 value of 22 nM [1]. Protein arginine methyltransferase-5 (PRMT5) is an enzyme that plays an important role in many cellular processes including tumorigenesis [1]. EPZ015666 is an orally bioavailable PRMT5 inhibitor. In a competitive inhibition model, EPZ015666 inhibited PRMT5 with Ki value of 5 nM and exhibited >20000-fold selectivity over 20 other protein methyltransferases (PMTs). In MCL cell lines Z-138, Mino, Maver-1, Granta-519 and Jeko-1, EPZ015666 decreased the level of SmD3, which was a PRMT5 substrate in a concentration-dependent way. Also, EPZ015666 reduced SmD3me2s in all cell lines. The cellular thermal shift assay (CETSA) in A375 cells showed that EPZ015666 specifically bound to PRMT5. EPZ015666 showed potent antiproliferative effects with IC50 values of 96, 450 and 61-904 nM for Z-138, Maver-1 and additional MCL cell lines respectively in a concentration-dependent way [1]. In SCID mice bearing Z-138 and Maver-1 xenografts, EPZ015666 (25, 50, 100 and 200 mg/kg) showed tumor-growth inhibition (TGI) in a dose-dependent way [1].

      • Properties
        • Alternative Name
          (R)-N-(3-(3,4-dihydroisoquinolin-2(1H)-yl)-2-hydroxypropyl)-6-(oxetan-3-ylamino)pyrimidine-4-carboxamide
          CAS Number
          1616391-65-1
          Molecular Formula
          C20H25N5O3
          Molecular Weight
          383.44
          Appearance
          A solid
          Purity
          98.54%
          Solubility
          insoluble in EtOH; insoluble in H2O; ≥19.17 mg/mL in DMSO
          Storage
          Store at -20°C

          * For Research Use Only

    We Also Recommend

    GNE-317

    $299

    Note: If you don't receive our verification email, do the following:

    Copyright © Amerigo Scientific. All rights reserved.